Rheumatology

Although there is no indication that older adults with chronic inflammatory conditions are at higher risk for developing dementing disease, the likelihood is that mild cognitive impairment will show up in your office.

Some of the latest developments in the use of these diagnostic tools for psoriatic arthritis were presented the annual meeting of the American College of Rheumatology Convergence 2020 in November.

Puja Khanna MD, MPH, associate professor of medicine at the University of Michigan, discusses a presentation she gave at the American College of Rheumatology Convergence 2020 on reducing the immunogenicity of pegloticase and improving its efficacy.

“The main take home message is to pay attention to the prevention and treatment of GIOP while prescribing steroids to the patients because the side effects is steroids are not benign," Shikha Singla, MD, said.

The approval was based on findings from the Belimumab International Study in Lupus Nephritis (BLISS-LN) study.

In this episode of Overdrive, the Rheumatology Network podcast, Dr. Kim Gorgens interviews Shereen Mahmood, MD, a rheumatologist with the Montefiore Medical Center in South Bronx, New York, to discuss her experience as a physician during the COVID-19 pandemic.

Ixekizumab appears to provide significantly greater simultaneous joint and skin improvement for patients with psoriatic arthritis than adalimumab and doesn’t require combination with methotrexate to boost its efficacy.

Findings from a study presented at ACR 2020 showed a clear difference in co-morbidities and medication use associated with osteoporosis at different lumbar levels. Here, a Q&A with the co-author.

Patients who had received tofacitinib combination therapy may be able to discontinue methotrexate.

The Centers for Medicare & Medicaid Services (CMS) has approved the final physician fee schedule for cognitive care reimbursement in the 2021 Medicare Physician Fee Schedule (MPFS).

The American College of Rheumatology (ACR) issued a statement on Wednesday objecting to a new Centers for Medicare and Medicaid Services (CMS) drug pricing rule the Trump Administration issued in November.

Young men with distal radius fracture are likely to have hormonal imbalances suggests the first study to look at sex hormone levels in younger men experiencing fractures.

Non-heterosexual minority men have a greater risk of poor bone health than heterosexual men, and this risk appears to be independent of lifestyle and psychosocial factors, suggests a study published in the American Journal of Human Biology.

Positive ACPA status may not necessarily mean a greater likelihood of osteoporosis and fracture for rheumatoid arthritis patients, study shows.

Continued use of low dose glucocorticoid in patients with rheumatoid arthritis also treated with stable DMARD therapy is associated with a small but significant risk of serious infection, show the results of a study published in Annals of Internal Medicine.

Adding rituximab to mycophenolate mofetil may necessitate a lower average daily dose of prednisone in patients with recalcitrant connective tissue disease–associated interstitial lung disease, but the combination treatment may not improve pulmonary function, shows a new study.

Many patients with vasculitis stopped taking immunosuppressive medications, avoided meeting with their doctor in person and failed to follow through on laboratory tests this year due to the COVID-19 pandemic.

Stories on COVID-19 were no doubt among our most read stories in 2020, but so too were stories on diet and rheumatic disease, rheumatoid arthritis treatment options, a new treatment for osteoarthritis and a story about selecting appropriate exercise regimens for rheumatic conditions. In this slideshow, we highlight the stories that resonated most with our readers in 2020.

In today's interview, our focus is on patient perspectives. During the American College of Rheumatology annual meeting last month, Juana Mata shared her story of a life living with lupus. Getting an accurate diagnosis wasn't easy, but eventually she found a doctor and treatment that's working for her. In today's interview, Kim Gorgens, a psychologist and Rheumatology Network board member interviews Juana and her sister, Estela, who describe turning a lupus diagnosis into a positive force for change through advocacy. The sisters have created a non-profit group called Looms for Lupus in which they embrace art therapy to relieve stress.

It is feasible to discontinue methotrexate in patients who had received tofacitinib combination therapy.